Search results
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 18 hours agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 16 hours agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA Today· 1 day agoWhen COVID-19 vaccines entered the commercial market last fall, the federal government introduced a...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots
Barrons.com· 3 days agoAfter disappointing sales for their Covid vaccines last year, Moderna, Novavax, and Pfizer are...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters· 3 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 15 hours ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 14 hours agoOther vaccine stocks are climbing as well. Shares of CureVac which, like Moderna, develops messenger...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 17 hours agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 5 days agoRival Moderna announced earlier this year that it would be pausing plans to build a plant in Kenya for vaccine development due to a drop in demand for...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 4 days agoIt is entitled to up to $700 million related to various clinical and regulatory milestones for ...
